| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.22T | — |
| Operating expense | — | — |
| Net income | 113.20B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TAK returned +17.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +16.6% |
| 1 year | +17.1% |
| 5 years | +17.1% |
| 10 years | -12.0% |
| All-time high | $29.50 (Jan 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TAK would be worth today ›No. Takeda Pharmaceutical Company Limited has not paid a dividend in the past 12 months.
Takeda Pharmaceutical Company Limited stock trades on NYSE under the ticker symbol TAK.
Takeda Pharmaceutical Company Limited is part of the Healthcare sector.
Takeda Pharmaceutical Company Limited has a market cap of 58.06B USD, based on the latest quote.
Takeda Pharmaceutical Company Limited is scheduled to report earnings on Oct 29, 2026.
